全文获取类型
收费全文 | 1023篇 |
免费 | 49篇 |
国内免费 | 28篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 115篇 |
妇产科学 | 24篇 |
基础医学 | 30篇 |
临床医学 | 141篇 |
内科学 | 126篇 |
神经病学 | 3篇 |
特种医学 | 50篇 |
外科学 | 181篇 |
综合类 | 191篇 |
预防医学 | 52篇 |
药学 | 101篇 |
1篇 | |
中国医学 | 57篇 |
肿瘤学 | 23篇 |
出版年
2023年 | 8篇 |
2022年 | 22篇 |
2021年 | 26篇 |
2020年 | 21篇 |
2019年 | 19篇 |
2018年 | 16篇 |
2017年 | 16篇 |
2016年 | 30篇 |
2015年 | 45篇 |
2014年 | 75篇 |
2013年 | 51篇 |
2012年 | 82篇 |
2011年 | 73篇 |
2010年 | 72篇 |
2009年 | 65篇 |
2008年 | 64篇 |
2007年 | 61篇 |
2006年 | 51篇 |
2005年 | 30篇 |
2004年 | 37篇 |
2003年 | 30篇 |
2002年 | 21篇 |
2001年 | 39篇 |
2000年 | 18篇 |
1999年 | 16篇 |
1998年 | 8篇 |
1997年 | 11篇 |
1996年 | 8篇 |
1995年 | 6篇 |
1994年 | 8篇 |
1993年 | 3篇 |
1992年 | 6篇 |
1991年 | 2篇 |
1990年 | 7篇 |
1989年 | 4篇 |
1988年 | 6篇 |
1987年 | 4篇 |
1986年 | 5篇 |
1985年 | 7篇 |
1984年 | 2篇 |
1981年 | 4篇 |
1980年 | 2篇 |
1978年 | 3篇 |
1977年 | 3篇 |
1976年 | 1篇 |
1974年 | 2篇 |
1973年 | 1篇 |
1972年 | 1篇 |
1971年 | 2篇 |
1970年 | 2篇 |
排序方式: 共有1100条查询结果,搜索用时 0 毫秒
1.
经内镜胆管引流术在肝门部恶性胆管梗阻中的应用及其评价 总被引:9,自引:2,他引:7
肝门部恶性肿瘤手术切除率极低,临床处理十分棘手。作者采用内镜胆管引流术治疗此类肿瘤288例次(肝门部胆管癌184例、胆囊癌23例、肝细胞癌侵犯肝门部胆管47例、其他转移性肿瘤34例),其中行内镜鼻胆管引流162例次、塑料内置管引流80例次、放置可膨式金属胆道支架46例、4例患者接受同期双内置管引流。引流总有效率为67.0%,其中效果满意者43.1%;40例患者术后1个月内发生胆管炎,发生率为13.8%,3例死亡;长期随访病例的平均存活期5.3个月。我们观察到治疗的效果与Bismuth分型有密切关系,如果全肝40%以上的胆系得到引流,黄疸有望消退;左、右两侧胆管同时引流可扩大引流范围,提高疗效;应合理选择三种内镜胆管引流方法并适时灵活转换才能获得满意的疗效。结论:对于肝门部肿瘤,内镜胆管引流术是一种安全有效的治疗手段,可作为首选的姑息性治疗。 相似文献
2.
目的研究重庆市新生儿黄疸儿G6PD三种常见基因突变与其临床表现特点之间的关系。初步估计其基因突变频率并探讨其临床意义和遗传学特征。方法应用突变特异性扩增系统(ARMS)法,检测54例重庆市新生儿黄疸儿的G6PD基因突变类型。结果检出G1388A突变39例(72%),G1376T突变8例(15%),未定型者7例(13%)。未检出G95A。结论本研究首次对重庆市新生儿黄疸儿进行G1388A、G1376T和A95G突变检测。提示G1388A和G1376T为重庆市新生儿黄疸儿G6PD缺乏症基因突变的主要类型。ARMS法是一种简便、快速、经济的检测G6PD已知基因突变的方法。本研究发现这两种突变类型仅见于中国人和华裔人群,具有遗传学及临床意义。 相似文献
3.
钟启腾 《中国自然医学杂志》2002,4(4):198-200
目的 对六草二苓汤治疗急性黄疸型病毒性肝炎的疗效进行对比临床研究,并探讨其作用机制。方法采用六草二苓汤的治疗组治疗急性黄疸型病毒性肝炎72例,并与使用肝泰乐、益肝灵、甘草甜素片的67例对照组作对比研究。结果 治疗组总有效率为93.1%,对照组总有效率为76.1%。在治疗后显效率、显效者复发率二方面,治疗组明显优于对照组(P<0.01)。在治疗前后主要症状体征变化、治疗前后肝功能变化、治疗后肝功能复常天数三方面,治疗组优于对照组(P<0.05)。结论 六草二苓汤治疗急性黄疸型病毒性肝炎,在较快地消除主要症状体征、消退黄疸、恢复肝功能、减少复发率方面有较好的疗效。 相似文献
4.
目的观察前列腺素E1治疗慢性乙型肝炎重度黄疸的疗效。方法在综合治疗基础上,分别使用前列腺素E1(治疗组)和门冬氨酸钾镁(对照组)治疗慢性乙型肝炎重度黄疸患者各35例,并观察其症状、体征及肝、肾功能等,疗程4周。结果治疗组的症状、体征及肝功能指标及总有效率,均显著优于对照组,两组比较差异有显著意义(P〈0.05)。结论前列腺素E1治疗慢性乙型肝炎重度黄疸能显著地促进黄疸消退和改善肝功能。 相似文献
5.
对蓝光照射治疗黄疸患儿家属实施健康教育的工作实践,证实了采用正确的教育方法,选择适宜的教育时期,提高了家属对黄疸患儿蓝光照射治疗意义的认识,促进护患家属间的交流,获得患儿及家属最大程度的配合与支持,有效地预防新生儿核黄疸的发生。 相似文献
6.
不能切除肿瘤的恶性梗阻性黄疸的外科姑息治疗方法繁多,本文介绍自1989年以来,采取开腹经不同途径的带支撑导管胆肠内引流的方法治疗30例,减黄确切,尚对7例高位胆管癌在解除胆道梗阻的基础上行术后(192)Ir和(60)Co联合放疗,提高了病人生存质量及延长了生命。 相似文献
7.
H. Knauf E. U. Kölle E. Mutschler 《Journal of molecular medicine (Berlin, Germany)》1990,68(13):692-698
Summary The disposition of the lipid-lowering drug gemfibrozil was studied in patients with either renal (n= 8) or hepatic disease (n= 8) and compared to those of healthy volunteers (n= 6). Gemfibrozil was determined in plasma and urine by means of a HPLC method. Urine was also analyzed for gemfibrozil conjugates.Following oral administration of 900 mg gemfibrozil, maximal plasma levels of the parent drug were 46.1±15.8 g/ml, attained after 2.2±1.1 h. In chronic renal failure and in liver cirrhosis the plasma concentrations of gemfibrozil did not significantly differ from that of controls except in those patients who were comedicated with antacids. These patients had significantly lower Cmax and AUC values. The elimination half-life of the drug was 1.5 h in controls, 2.4 h in renal failure, and 2.1 h in liver disease. In healthy volunteers, only 0.02 to 0.15% of the given dose was recovered in the urine as parent gemfibrozil, while conjugates made up 7–14%. In patients with renal failure also, only traces of parent gemfibrozil could be detected, and conjugates accounted for 0.5–9.8%. In those with liver disease, however, about 0.1–0.2% were recovered in urine as parent gemfibrozil and up to 50% as conjugates. Strikingly, the amount of excreted conjugates in the urine was positively correlated to the direct bilirubin plasma concentration. It can be concluded that the elimination of gemfibrozil is not significantly influenced by renal failure. However, comedication with antacids markedly reduced plasma disposition of the drug. Patients with severe liver disease excreted more conjugated gemfibrozil via the kidney than did healthy controls. Thus, transfer across the canalicular cell membrane to the bile duct, rather than drug metabolization, is primarily disturbed in liver disease. Gemfibrozil accumulation is unlikely to occur in either kidney or liver disease.Abbreviations Clr
creatinine clearance (ml/min)
- HPLC
high pressure liquid chromatography
- Cmax
maximal plasma concentration (g/ml)
- tmax
time (h) after which Cmax is attained
- ke
elimination rate constant (h–1)
- t1/2
elimination half-life (h)
- Ae
amount of drug excreted into the urine (% of given dose)
- MRT
mean residence time (h)
- AUMC
area under the first moment curve (g h2/ml)
- AUC
area under the plasma level time curve (g·h/ml)
- ANOVA
analysis of variance
The paper is gratefully dedicated to G.W. Löhr 相似文献
8.
D W Johnson C Safai D R Goffinet 《International journal of radiation oncology, biology, physics》1985,11(2):411-416
Eleven patients with obstructive jaundice from unresectable cholangiocarcinoma, metastatic porta hepatis adenopathy, or direct compression from a pancreatic malignancy were treated at the Stanford University Medical Center from 1978-1983 with an external drainage procedure followed by high-dose external-beam radiotherapy and by an intracavitary boost to the site of obstruction with Iridium192 (Ir192). A median dose of 5000 cGy was delivered with 4-6 Mv photons to the tumor bed and regional lymphatics in 9 patients, 1 patient received 2100 cGy to the liver in accelerated fractions because of extensive intrahepatic disease, and 1 patient received 7000 "equivalent" cGy to his pancreatic tumor bed and regional lymphatics with neon heavy particles. An Ir192 wire source later delivered a 3100-10,647 cGy boost to the site of biliary obstruction in each patient, for a mean combined dose of 10,202 cGy to a point 5 mm from the line source. Few acute complications were noted, but 3/11 patients (27%) subsequently developed upper gastrointestinal bleeding from duodenitis or frank duodenal ulceration 4 weeks, 4 months, and 7.5 months following treatment. Eight patients died--5 with local recurrence +/- distant metastasis, 2 with sepsis, and 1 with widespread systemic metastasis. Autopsies revealed no evidence of biliary tree obstruction in 3/3 patients. Mean survival time from initial laparotomy and bypass was 16.1 months, and from radiotherapy completion was 8.3 months. Evolution of radiation treatment techniques for biliary obstruction in the literature is reviewed. High-dose external-beam therapy followed by high-dose Ir192 intracavitary boost is well tolerated and provides significant palliation. Survival of these aggressively managed patients approaches that of patients with primarily resectable tumors. 相似文献
9.
Rüdiger Schwarzrock Jörg Kotzerke Heinz Hundeshagen Klaus Böcker Burckhard Ringe 《European journal of nuclear medicine and molecular imaging》1986,12(7):346-350
The new HIDA derivative, 99mTc-dimethyl-iodine-HIDA (JODIDA), was compared with 99mTc-diisopropyl-HIDA (DISIDA) in 17 patients with jaundice by means of paired cholescintigraphic imaging studies. The following parameters were visually assessed: the extent of urinary tract visualization, biliary contrast and appearance time, and gallbladder visualization and appearance time. In the 6 patients with a total bilirubin level of between 19 and 66 mol/l (1.1 and 3.9 mg/dl), both radiopharmaceuticals gave similar results except for the moderate visualization of the urinary tract with DISIDA in contrast to JODIDA. In the remaining 11 patients with a total bilirubin level between 102 and 1303 mol/l (6 and 76 mg/dl), JODIDA showed significant advantages over DISIDA: non-visualization of the urinary tract, stronger and faster biliary contrast, and better gallbladder visualization. JODIDA thus offered substantial diagnostic advantages over DISIDA in 8 of these patients. In 4 patients, the differential diagnosis of jaundice (intrahepatic or mechanical disorder) was possible with JODIDA, whereas DISIDA either could not visualize intestinal or gallbladder activity at all or could not differentiate it from the urinary tract. In one patients, JODIDA offered faster (18 h) diagnosis. In the remaining 3 patients, other, substantially false interpretations could be avoided through the use of JODIDA. Further clinical experience with JODIDA in more than 40 patients confirmed the results of this study. We concluded that JODIDA is of significant advantage over DISIDA in clinical situations such as total bilirubin level above 80–100 mol/l (4.7 to 5.8 mg/dl), examination of small children and critically ill patients and suggestion of bile leakage. As there are also no clinical disadvantages, it could become the rediopharmaceutical of choice for hepatobiliary imaging. 相似文献
10.
目的 :探讨 (Dubin Johnsonsyndrome ,DJS)的诊断和鉴别方法。 方法 :对北京医科大学第三医院 196 0~1998年确诊的 10例DJS进行回顾性分析及文献复习。结果 :DJS以慢性持续或间歇性黄疸为主要特征 ,血清胆红素一般轻度升高且以结合胆红素为主 ,ALT及AST正常 ;但并发病毒性肝炎或其它肝病时可升高。口服胆囊造影不显影 ;BSP试验呈典型双峰曲线 ,该方法已被淘汰。腹腔镜下肝脏呈特征性“黑肝”改变 ;肝活检细胞内有棕色或棕黄色色素颗粒沉着。结论 :腹腔镜检查和 /或肝活检是DJS诊断和鉴别诊断的重要方法。 相似文献